USE OF BIOTECHNOLOGY IN DRUG PRODUCTION / A REVIEW ARTICLE

Authors

  • Dr. Ihab Q. Ali Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq, Baghdad
  • Shahla hussien huno Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq, Baghdad
  • Dr. Abdalkader Saeed Latif National University of Science and Technology / College of Health and Medical Technology
  • Dr.Noor Naji Ajmi Msc student /clinical biochemistry of medical science/ Bachelor of pharmacy College Baghdad University

Keywords:

Biotechnology, Drug Production, Medical Challenges

Abstract

Since the early 1970s, biotechnological advancements have progressed under established guidelines and local laws. Comprehensive examinations have revealed no unexpected or unmanageable characteristics in recombinant organisms. This technology has proven invaluable, enabling numerous medical advancements through therapeutic proteins that are otherwise unattainable. In developed countries, biotechnology has emerged as a significant economic force, driving substantial industry growth during the biotechnological revolution

References

Anand, U., Jacobo-Herrera, N., Altemimi, A. and Lakhssassi, N. (2019). A comprehensive review on

medicinal plants as antimicrobial therapeutics: potential avenues of biocompatible drug discovery.

Metabolites, 9(11), 258.

Badalyan, S. M., Barkhudaryan, A. and Rapior, S. (2019). Recent progress in research on the

pharmacological potential of mushrooms and prospects for their clinical application. Medicinal mushrooms:

recent progress in research and development, 1-70.

Morin-Crini, N., Lichtfouse, E., Torri, G. and Crini, G. (2019). Applications of chitosan in food,

pharmaceuticals, medicine, cosmetics, agriculture, textiles, pulp and paper, biotechnology, and

environmental chemistry. Environmental Chemistry Letters, 17(4), 1667-1692.

Das, K., and Paital, B. (2020). First week of social lockdown versus medical care against COVID-19-with

special reference to India. Current Trends in Biotechnology and Pharmacy, 14(2), 196-216.

Marchev, A. S., Yordanova, Z. P. and Georgiev, M. I. (2020). Green (cell) factories for advanced

production of plant secondary metabolites. Critical reviews in biotechnology, 40(4), 443-458.

Shrestha, J., Razavi Bazaz, S., Aboulkheyr Es, H., Yaghobian Azari, D., Thierry, B., Ebrahimi Warkiani,

M. and Ghadiri, M. (2020). Lung-on-a-chip: the future of respiratory disease models and pharmacological

studies. Critical reviews in biotechnology, 40(2), 213-230.

Jain, A. K. and Thareja, S. (2019). In vitro and in vivo characterization of pharmaceutical nanocarriers

used for drug delivery. Artificial cells, nanomedicine, and biotechnology, 47(1), 524-539.

Ansari, F., Pourjafar, H., Tabrizi, A. and Homayouni, A. (2020). The effects of probiotics and prebiotics

on mental disorders: a review on depression, anxiety, Alzheimer, and autism spectrum disorders. Current

pharmaceutical biotechnology, 21(7), 555-565.

Downloads

Published

2024-07-19

How to Cite

Dr. Ihab Q. Ali, Shahla hussien huno, Dr. Abdalkader Saeed Latif, & Dr.Noor Naji Ajmi. (2024). USE OF BIOTECHNOLOGY IN DRUG PRODUCTION / A REVIEW ARTICLE. European Journal of Humanities and Educational Advancements, 5(7), 3-6. Retrieved from https://scholarzest.com/index.php/ejhea/article/view/4635

Issue

Vol. 5 No. 7 (2024): EJHEA

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)